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Methods: Retinal images from a narrow-age cohort were analyzed using Vessel Assessment and
Measurement Platform for Images of the Retina, producing a comprehensive range of quantitative
measurements of the retinal vasculature, at mean age 72.5 years (SD 5 0.7). Cognitive ability and
change were measured using a battery of multiple measures of memory, visuospatial, processing
speed, and crystallized cognitive abilities at mean ages 73, 76, and 79 years. We applied multivariate
growth curve models to test the association between retinal vascular measurements with cognitive
abilities and their changes.
Results: Almost all associations were nonsignificant. In our most parsimonious model, venular
asymmetry factor was associated with speed at age 73.
Discussion: Our null findings suggest that the quantitative retinal parameters applied in this study are
not significantly associated with cognitive functioning or cognitive change.
 2019 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Keywords: Retinal imaging; Cognitive change; Longitudinal study1. Introduction
Owing to the homology between retinal and brain
microvasculature, it has been hypothesized that retinal ves-
sels might act as a surrogate marker of the brain microvas-terest: none.
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he Authors. Published by Elsevier Inc. on behalf of the Alzh
ns.org/licenses/by/4.0/).culature, with age-related changes to the retinal vessels
providing an indirect marker of homologous changes to
the vessels within the brain [1]. It has also been proposed
that age-related retinal microvasculature changes might
be associated with cognitive decline, providing an approx-
imation of the impact on cerebral small-vessel disease on
cognitive functioning [2]. With the growing interest in
the application of retinal vasculature to gain insight into
the state of systemic and brain microcirculation and,
perhaps, thereby to later-life cognitive functioning, it iseimer’s Association. This is an open access article under the CC BY license
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are associated with cognitive functioning and cognitive
change in later life.
Cross-sectional studies examining features of retinal
microvascular pathological changes and cognitive outcomes
(delayed word recall and digit symbol substitution scores)
have reported generally consistent, modest associations
(odds ratio [OR]: 2.6; 95% confidence interval [CI] 5 1.3–
2.91; OR: 2.18; 95% CI 5 1.02–4.64) [2,3]. Evidence of
associations between quantitative nonpathological retinal
microvascular measurements and cognitive aging has been
mixed. Lower fractal dimension of the retinal vasculature
was associated with cognitive dysfunction (OR: 1.71; 95%
CI 5 1.03-2.82) in the Singapore Malay Eye Study [4].
The Blue Mountains Eye Study reported an association be-
tween venular dilation and cognitive impairment (OR: 1.8;
95% CI 5 1.0-3.2) [5]. However, other studies have found
little evidence that such quantitative retinal microvascular
measurements are associated with nonpathological cognitive
aging [6–9].
Longitudinal studies examining retinal microvasculature
changes in relation to cognitive changes have found some
evidence for the role of microvascular disease in cognitive
decline, with marginal associations between retinal features
and cognitive decline. Retinal microvascular pathology in
particular has been associated with an increased risk of
cognitive decline. The Atherosclerosis Risk in Communities
Study found declines in processing speed and executive
functioning and attention (OR: 2.18 and 1.33, respectively)
over 14 years [2], with a follow-up study reporting differ-
ence in 20-year cognitive change for moderate/severe versus
no retinopathy (standard deviation [SD]: 20.53, 95% CI 5
20.74 to 20.33) [10]. Haan et al. reported poor modified
Mini-Mental State Examination scores (mean difference:
1.01, standard error: 0.43) in those with retinopathy [11].
The few studies examining vessel width in relation to cogni-
tive change have found little evidence to support an associ-
ation between arteriolar and venular diameters and cognitive
decline [2,10,12].
To our knowledge, no studies have been published to date
examining trajectories of different major cognitive domains
and their associations with a wide range of retinal vascular
features. Most longitudinal studies have focused on specific
retinal measures such as retinopathy signs (microaneurysms,
soft or hard exudates, retinal hemorrhages, macular edema,
intraretinal microvascular abnormalities, venous beading,
new vessels, vitreous hemorrhage, disc swelling, or laser
photocoagulation scars) [2,11,13–15] or arteriolar
narrowing, focal narrowing, or arteriolar nicking [2,13,14];
the present study analyzed a wide range of quantitative
retinal vascular parameters including both local and global
vascular topographic features (including branching angles
of vessels, tortuosity, and fractal dimension). These
features are thought to reflect how optimally arranged and
developed the retinal microvasculature is and therefore
may indicate the state of the cerebral microcirculation[16]. These changes are milder than pathological signs of
retinopathy but are more common, which increases the prog-
nostic value of these features should an association be found.
We assessed cognitive functioning levels at age 73 and
cognitive changes from age 73 to age 79 in a range of highly
sensitive cognitive tests measuring four distinct domains of
cognition using multiple tests for each domain: memory,
processing speed, visuospatial ability, and crystallized abil-
ity [17]. The present study, therefore, aims to test which, if
any, retinal vascular measurements are associated with
between-person variation in cognitive levels at baseline
and predict future changes, both in specific, major cognitive
ability domains and more generally across all cognitive abil-
ities, between age w73 to 79 years, after controlling for a
range of relevant covariates.2. Methods
2.1. Participants
The Lothian Birth Cohort 1936 (LBC1936) is a prospec-
tive study of a narrow-age sample of community-dwelling in-
dividuals, living mostly in the city of Edinburgh and the
surrounding Lothian area of Scotland, UK [18–20]. All
participants were born in 1936, and most took a general
mental ability test in the Scottish mental survey of 1947 at
age 11. Those living in the Edinburgh area at about
70 years of age were invited to be recruited in the
LBC1936 longitudinal study. Participants were followed up
in 2004-2007 (wave 1: mean age: 69.5 years, SD 5 .08;
n 5 1,091, 543 women), again in 2007-2011 (wave 2:
mean age: 72.5 years, SD 5 0.07; n 5 866, 418 women),
again in 2011-2013 (wave 3: mean age: 76.3 years,
SD 5 0.07; n 5 697, 337 women), and again in 2014-2017
(wave 4: mean age: 79.3 years, SD 5 0.6; n 5 550, 275
women). Retinal imaging was performed at wave 2 at a
mean age of about 73 years; cognitive, physical, and health
assessments were performed concurrently and again at
waves 3 and 4, at mean ages of 76 and 79 years,
respectively. Those with retinal measurements from both
right and left eyes formed the analytic sample for the
present study (n 5 603). Retinal imaging and all data
analyses were performed blind to all other results including
cognitive ability.
Written informed consent was obtained from all partici-
pants. The research was carried out in compliance with the
Helsinki Declaration. The study was approved by the Multi-
centre Research Ethics Committee for Scotland (MREC/01/
01/56; 07/MRE00/58) and the Lothian Research Ethics
Committee (LREC/2003/3/29).
2.2. Measures2.2.1. Retinal measurements
Digital fundus retinal images of the right and left retinas
were captured using a nonmydriatic camera and a 45 field
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ages were analyzed by a trained grader (S.M.) at the Univer-
sity of Edinburgh, using the semiautomated software Vessel
Assessment and Measurement Platform for Images of the
Retina (VAMPIRE) [21–23]. A total of 814 participants
had retinal images of both eyes taken at wave 2. Retinal
parameters from these images were measured for each of
the 680 participants whose images were of sufficient
quality for analysis using VAMPIRE, which resulted in a
sample of 603 with retinal measurements of both eyes.
Supplementary Fig. S1 shows a flowchart of how the analytic
sample for the present study was derived. The main reasons
for image rejection included images being centered overly
toward the macula resulting in too few visible vessels; im-
ages with known pathologies, including cataract and asteroid
hyalosis; images being of very poor quality, including out-
of-focus images; small pupil size leading to dark images;
and overexposure. In brief, retinal vascular parameters
were measured from the vessel caliber—central retinal ar-
tery equivalent, central retinal vein equivalent, and the vari-
ation in caliber—the standard deviation of arteriolar and
venular widths; measures of branching complexity—arteri-
olar and venular fractal dimension; measures of vessel tortu-
osity—arteriolar and venular tortuosity; and measures of
arteriolar and venular branching geometry—branching coef-
ficient, length-diameter ratio, and asymmetry factor. Four-
teen measurements were calculated from each retinal
image. These measurements were selected from a larger
range of VAMPIRE measurements through a data reduction
process described in detail previously [24]. To reduce the
number of variables, reduce multicollinearity, and increase
reliability, the abovementioned measurements from both
eyes of each participant were averaged to provide a mean
measurement for all variables. A description of all parame-
ters is listed in Supplementary Table S1. Separate arteriolar
and venular measures are indicated by lowercase “a” or “v”.
2.2.2. Cognitive tests
All cognitive tests and administration procedures have
been described in detail previously [18]. Following previous
analyses on this battery of cognitive tests [17], the measure-
ment of cognitive ability was grouped into four domains de-
signed to assess multiple aspects of cognitive functioning:
memory, processing speed, visuospatial ability, and crystal-
lized intelligence. Memory was measured by logical mem-
ory, verbal paired associates, and digit span backwards
from the Wechsler Memory Scale Third Edition [25]. Pro-
cessing speed was measured by symbol search and digit
symbol from the Wechsler Adult Intelligence Scale Third
Edition (WAIS-III) [26]. Choice Reaction Time and Inspec-
tion Time: inspection time and choice reaction time tests and
procedures have been described in detail [27,28].
Visuospatial ability was measured with block design andmatrix reasoning from the WAIS-III and spatial span for-
ward and spatial span backward from the WMS-III. Crystal-
lized intelligence was measured by the Wechsler Test of
Adult Reading [29], the National Adult Reading Test [30],
and phonemic verbal fluency test [31].2.2.3. Covariates
Age (in days at time of retinal imaging and cognitive
testing) and sex were included as covariates. Heath assess-
ments carried out at testing included self-reported medical
history (recording histories [yes, no] of hypertension, hy-
percholesterolemia, and diabetes), and smoking status,
(current vs. ex or never). Systolic and diastolic blood pres-
sure (average of three sitting measures), plasma hemoglo-
bin A1c, and total serum cholesterol were also measured
during physical assessment with a research nurse.
Including these covariates, which have been previously
linked to cognitive aging and retinal measurements, al-
lowed us to determine if they have any confounding effects
on the hypothesized association between retinal measure-
ments and cognitive ability.2.6. Statistical analysis
Data were analyzed using a multivariate latent growth
curve approach, implemented inMplus (version 7.4) [32] us-
ing full-information maximum likelihood estimation to take
all data into account. The model estimated the overall level
of each cognitive test (the intercept at mean age 73 years)
and the slope of its change across the three measurement
waves (the trajectory between age 73 and 79 years). In doing
so the model estimated the association of each retinal
vascular feature with the overall level of each cognitive
test and the slope of its change. The average time lag be-
tween the waves (3.77 years from waves 2 to 3, and
6.87 years from waves 2 to 4) was used as the path weights
for calculation of the slope factor, with the path from the
slope factor to the initial wave’s (wave 2) test score being
set to zero. A ‘factor of curves’ model was used with latent
level and slope factors analyzed as if they were directly
measured variables, allowing their organization into
higher-order factor structures to be investigated and their re-
lations with covariates [33].
A single general factor was estimated from the growth
curve levels for each test. We then tested whether it was
possible to extract a general factor of cognitive change
from the growth curve slopes. Model fit was tested using
four indices of absolute fit: root mean square error of approx-
imation (values, 0.06 considered acceptable), comparative
fit index (values . 0.95 considered acceptable), Tucker-
Lewis index (values . 0.95 considered acceptable), and
standardized root mean square residual (values , 0.08
considered acceptable).
Table 1
Descriptive statistics for each cognitive test and covariate at each testing wave
Variable Age 73 (wave 2) Age 76 (wave 3) Age 79 (wave 4)
N 603 492 391
Sex
Female 300 (49.8) 242 (49.2) 199 (50.9)
Male 303 (50.2) 250 (50.8) 192 (49.1)
Age 72.5 (0.7) 76.25 (0.67) 79.36 (0.70)
Cognitive tests n M SD n M SD n M SD
Visuospatial
Matrix reasoning 603 13.23 5.00 487 13.04 4.94 383 12.98 5.02
Block design 602 33.89 10.07 489 32.30 9.97 382 31.19 9.86
Spatial span 601 7.36 1.39 488 7.33 1.40 385 7.10 1.39
Crystallized
NART 603 34.50 8.29 492 35.24 7.92 389 35.83 8.15
WTAR 603 41.22 6.95 492 41.30 6.91 389 41.84 6.97
Verbal fluency 603 43.61 12.94 491 43.36 12.75 389 43.79 13.42
Verbal paired associates 601 74.08 17.92 484 74.05 19.51 385 72.71 19.80
Memory
Logical memory 589 27.28 9.32 469 26.24 9.75 358 27.07 9.46
Digit span backward 603 7.85 2.29 490 7.80 2.36 389 7.64 2.16
Symbol search 603 24.91 6.00 488 24.83 6.48 381 22.80 6.70
Speed
Digit symbol 602 57.20 11.93 488 54.27 12.74 385 51.58 12.85
Inspection time 591 111.77 11.64 466 110.64 12.57 337 106.76 14.06
Choice reaction time 603 0.64 0.08 487 0.68 0.10 388 0.70 0.11
Covariates
HbA1C 575 5.72 0.60 349 5.84 0.63 10 5.69 0.20
Cholesterol 581 5.24 1.16 451 5.04 1.22 371 5.04 1.20
Systolic blood pressure 600 148.48 18.99 489 147.86 19.57 388 145.14 18.99
Diastolic blood pressure 600 78.22 9.59 489 78.88 10.09 388 76.85 9.90
Covariates (dichotomous) n total n present n absent n total n present n absent n total n present n absent
Smoker/ex-smoker 603 303 300 491 234 257 391 179 212
Stroke 603 33 570 492 47 445 389 47 342
Cardiovascular disease 603 161 442 492 163 328 390 139 251
Hypertension 603 270 333 492 256 236 391 218 173
Diabetes 603 58 545 492 58 434 389 51 338
Hypercholesterolemia 603 228 375 489 223 266 388 171 217
APOE e4 574 166 408
NOTE: The means here are raw and not FIML-estimated. Values are mean (SD) or N (%) unless otherwise stated.
Abbreviations: NART, National Adult Reading Test; WTAR, Wechsler Test of Adult Reading; HbA1C, plasma hemoglobin A1c.
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age and sex; and second, we additionally adjusted for
vascular risk factors (VRF). Vascular risk was measured
by systolic and diastolic blood pressure, blood cholesterol,
blood hemoglobin A1c, hypertension, hypercholesterole-
mia, and smoking. This allowed us to compare the associa-
tion between retinal measurements and cognition with and
without controlling for VRF.
The large number of significance tests in these models in-
creases the potential for type I errors. For that reason, P
values were corrected for multiple comparisons using Hoch-
berg’s false discovery rate (FDR) correction [34].3. Results
There were 603 participants of mean age 72.5 years
(SD 5 0.7) at wave 2, 492 participants of mean age76.2 years (SD 5 0.7) at wave 3, and 391 participants of
mean age 79.4 years (SD5 0.7) at wave 4. Table 1 provides
the cognitive test results and vascular risk factor findings at
each wave.3.1. Prediction of study (non)attendance
Table 2 shows differences between participants who
provided cognitive ability or retinal imaging data at all
three waves (“completers”), n 5 391, and those who pro-
vided data at only one or two waves (“noncompleters”),
n 5 212. Those who completed all waves of the study
scored higher on all cognitive tests, had lower systolic
blood pressure, had lower rates of diabetes, and were less
likely to be smokers at age 73 (wave 2). Retinal measure-
ments of completers and noncompleters did not differ,
with the exception of arteriolar fractal dimension, where
Table 2
Differences at age 73 between participants who provided data at all three waves (“completers”) and participants who provided data at one or two waves
(“noncompleters”)
Characteristics at wave 2 Completers total n 5 391 n* Noncompleters total n 5 212 ny P
Matrix reasoning, M (SD) 13.88 (4.92) 390 12.04 (4.94) 212 ,.001
Block design, M (SD) 34.91 (10.01) 390 32.02 (9.93) 212 .001
Spatial span, M (SD) 7.46 (1.35) 389 7.18 (1.43) 212 .017
Paired associates, M (SD) 28.30 (8.87) 384 25.37 (9.96) 205 ,.001
Logical memory, M (SD) 75.79 (16.75) 391 70.91 (19.56) 210 .001
Digit span, M (SD) 7.99 (2.34) 391 7.59 (2.16) 212 .040
NART, M (SD) 35.24 (8.10) 391 33.15 (8.47) 212 .003
WTAR, M (SD) 41.86 (6.66) 391 40.04 (7.32) 212 .002
Verbal fluency, M (SD) 44.52 (12.89) 391 41.93 (12.89) 212 .019
Digit symbol, M (SD) 58.67 (11.83) 391 54.49 (11.66) 211 ,.001
Symbol search, M (SD) 25.65 (5.84) 391 23.54 (6.08) 212 ,.001
Reaction time, M (SD) 26.36 (0.78) 391 26.61 (0.92) 212 ,.001
Inspection time, M (SD) 112.47 (11.58) 389 110.42 (11.65) 202 .042
CRAE, M (SD) 31.25 (2.23) 391 31.06 (2.17) 212 .335
CRVE, M (SD) 42.21 (3.14) 391 41.94 (3.24) 212 .318
BSTDa, M (SD) 2.17 (0.64) 391 2.27 (0.68) 212 .061
BSTDv, M (SD) 3.96 (0.88) 391 3.91 (0.87) 212 .551
FDa, M (SD) 1.59 (0.05) 391 1.58 (0.05) 212 .008
FDv, M (SD) 1.57 (0.04) 391 1.56 (0.05) 212 .053
TORTa, M (SD) 29.993 (0.95) 391 29.969 (0.97) 212 .769
TORTv, M (SD) 29.911 (0.70) 391 29.923 (0.68) 212 .841
BCa, M (SD) 2.10 (0.24) 357 2.09 (0.34) 179 .743
BCv, M (SD) 2.08 (1.78) 361 1.96 (0.20) 195 .340
AFa, M (SD) 0.92 (0.04) 357 0.92 (0.05) 179 .890
AFv, M (SD) 0.90 (0.05) 361 0.90 (0.05) 195 .097
LDRa, M (SD) 19.71 (5.33) 357 19.19 (5.22) 179 .280
LDRv, M (SD) 19.15 (4.99) 361 18.66 (5.18) 195 .281
Cholesterol mmol/L, M (SD) 5.29 (1.14) 381 5.14 (1.19) 200 .146
HbA1C, M (SD) 5.70 (0.53) 379 5.76 (0.71) 196 .189
Diastolic BP, M (SD) 77.92 (9.44) 389 78.78 (9.86) 211 .291
Systolic BP, M (SD) 147.34 (17.78) 389 150.57 (20.92) 211 .047
Hypertension, N (%) 165 (42.2) 391 105 (49.5) 212 .084
Diabetes, N (%) 29 (7.4) 391 29 (13.7) 212 .013
High cholesterol, N (%) 149 (38.1) 391 79 (37.3) 212 .838
Smoker/ex-smoker, N (%) 180 (46) 391 123 (58) 212 .005
Abbreviations: NART, National Adult Reading Test; WTAR, Wechsler Test of Adult Reading; CRAE, central retinal arteriolar equivalent; CRVE, central
retinal venular equivalent; BSTDa, standard deviation of arteriolar widths in zone B; BSTDv, standard deviation of venular widths in zone B; FDa, arteriolar
fractal dimension; FDv, venular fractal dimension; TORTa, arteriolar tortuosity; TORTv, venular tortuosity; BCa, arteriolar branching coefficient; BCv, venular
branching coefficient; AFa, arteriolar asymmetry factor; AFv, venular asymmetry factor; LDRa, arteriolar length-to-diameter ratio; LDRv, venular length-to-
diameter ratio.
*Number of completers with available data at age 73.
yNumber of noncompleters with available data at age 73.
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vascular complexity.
3.2. Structure of cognitive change
In our model, nine of the 13 cognitive tests’ slopes had
specific variances (between person differences in slope)
that were near-zero and were estimated as negative, indi-
cating that all variance in change on that test was shared
with the aforementioned domain (i.e., they have a stan-
dardized loading of 1.0). In addition, the slope of one of
the domains (visuospatial) also had negative variance.
We fixed the specific variance of these slopes (matrix
reasoning, spatial span, National Adult Reading Test, ver-bal fluency, logical memory, digit span backwards, symbol
search, inspection time, choice reaction time, visuospatial)
to zero, to allow our model to converge on within-bound
estimates (with no negative variance). The model fit
well by root mean square error of approximation
(0.038), comparative fit index (0.961), Tucker-Lewis in-
dex (0.959), and standardized root mean square residual
(0.066) (Fig. 1).
3.3. Predictors of cognitive level and change
At mean age 73, those with better cognitive function were
younger when tested (standardized b 5 .165, P , .001).
Women tended to perform better than men in tests of
Fig. 1. Structural model of cognitive ability levels (A) and slopes (B). The latent levels and slopes of each test are grouped into domains; these domains are
grouped under the general factor of cognitive ability. Values are standardized factor loadings. Both A and B were estimated simultaneously in the model.
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(b 5 .459, P , .001), and men scored better than women in
tests of visuospatial ability (b 5 2.621, P , .001).3.4. Retinal predictors of cognitive level and change
Importantly, a large number of the associations were not
significant even before correction for multiple comparisons.
Across both models, only 18 of the 280 retinal-cognitive
function associations were nominally significant. Of these,
only one association in the age- and sex-adjusted model sur-
vived correction for multiple comparisons; venular asymme-
try factor was associated with speed at age 73 (b 5 2.129,
P , .001, FDR corrected P , .001), such that participants
with slower processing speed at age 73 tended to have higher
asymmetry factor measurements, indicating greater sym-
metrical widths of daughter branching venules (see
Table 3). Eight nominally significant associations in the
age- and sex-adjusted model were lost after FDR adjustment(see Table 3). In the age-, sex-, and VRF-adjusted model,
none of the 10 nominally significant associations survived
FDR correction (all results are shown in Supplementary
Table S2 in Supplemental materials).4. Discussion
Our study provides data on a wide array of retinal
vascular features, addressing the question of whether indi-
vidual differences in these measurements are associated
with differences in the age 73 levels of, and age 73–79
changes in, cognitive abilities. Our results provide no evi-
dence to support the use of quantitative retinal vascular
measurements to predict nonpathological cognitive aging
in a relatively healthy sample of this age and background.
There were very few associations between retinal predic-
tors and both domain-general and domain-specific cogni-
tive levels and declines. After correcting for multiple
comparisons, only one modest-sized association
Table 3
Associations of each predictor, entered individually alongside age, sex, with the cognitive level, and slope (cognitive aging from 73 to 79) of cognitive ability
from mean age. General factor model and domain models were run separately
Covariate
General factor
estimate (SE) Domain factor estimate (SE)
g
level
g
slope
Visuospatial
level
Crystallized
level
Verbal
memory
level
Speed
level
Visuospatial
slope
Crystallized
slope
Verbal
memory
slope
Speed
slope
Age
(baseline)
2.165
(.044)*
2.034 (.054) .013 (.037) 2.072 (.034)y .000 (.041) 2.082 (.035)y .149 (.093) 2.098 (.083) 2.031 (.050) .011 (.049)
Sex
(female)z
.076
(.097)
.179 (.109) 2.623 (.064)* .271 (.068)* .459 (.079)* .109 (.075) .136 (191) .035 (.159) .140 (.103) .017 (.102)
CRAE 2.009
(.046)
.082 (.055) 2.018 (.034) 2.033 (.034) 2.026 (.040) .049 (.035) .043 (.094) .014 (.081) 2.028 (.051) .060 (.050)
CRVE .065
(.046)
.055 (.055) 2.026 (.033) .040 (.033) 2.025 (.039) .041 (.035) .040 (.092) 2.161 (.084) .042 (.052) .044 (.050)
BSTDa 2.019
(.045)
2.021 (.054) .026 (.034) 2.029 (.034) .038 (.039) 2.044 (.035) .052 (.095) 2.051 (.082) 2.057 (.050) .011 (.049)
BSTDv .008
(.045)
.042 (.055) .016 (.033) 2.003 (.034) 2.014 (.040) .007 (.035) 2.153 (.089) 2.030 (.084) .020 (.051) .072 (.050)
FDa .056
(.047)
.131 (.057)y 2.022 (.035) 2.033 (.035) 2.029 (.041) .078 (.036)y .126 (.100) .093 (.089) 2.035 (.056) .056 (.054)
FDv .009
(.045)
.066 (.055) 2.047 (.034) 2.040 (.034) .051 (.040) .030 (.035) .137 (.092) .124 (.084) 2.078 (.052) .024 (.050)
TORTa .132
(.045)y
.065 (.054) .011 (.034) .018 (.034) 2.013 (.040) .046 (.035) .110 (.094) 2.144 (.081) .049 (.051) .005 (.050)
TORTv 2.026
(.045)
2.016 (.054) .000 (.034) 2.030 (.034) 2.021 (.040) .018 (.035) .055 (.092) .020 (.080) .087 (.050) 2.085 (.048)
BCa .051
(.048)
2.017 (.058) .024 (.036) .014 (.035) 2.034 (.042) 043 (.037) 2.126 (.100) .146 (.092) .042 (.054) 2.068 (.054)
BCv 2.002
(.048)
.040 (.049) .082 (.034)y 2.095 (.035)y 2.056 (.042) .021 (.036) .032 (.081) 2.039 (.067) .024 (.044) .001 (.042)
AFa 2.060
(.048)
2.016 (.059) .043 (.036) 2.010 (.035) 2.017 (.043) 2.058 (.037) 2.116 (.099) .044 (.092) .048 (.055) 2.010 (.054)
AFv 2.049
(.048)
.058 (.056) .056 (.035) 2.021 (.035) .053 (.042) 2.129 (.035)* .043 (.096) 2.007 (.077) .068 (.051) 2.003 (.049)
LDRa .080
(.048)
.019 (.058) .015 (.036) 2.046 (.035) .042 (.093) .088 (.037)y 2.144 (.097) .152 (.093) 2.018 (.018) .017 (.054)
LDRv .002
(.047)
.106 (.056) .057 (.035) 2.024 (.035) 2.013 (.042) 2.028 (.036) 2.213 (.089)y 2.043 (.079) .021 (.053) .141 (.050)y
NOTE. Bolded values are statistically significant.
Abbreviations: g, general factor; SE, standard error; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; BSTDa, standard
deviation of arteriolar widths in zone B; BSTDv, standard deviation of venular widths in zone B; FDa, arteriolar fractal dimension; FDv, venular fractal dimen-
sion; TORTa, arteriolar tortuosity; TORTv, venular tortuosity; BCa, arteriolar branching coefficient; BCv, venular branching coefficient; AFa, arteriolar asym-
metry factor; AFv, venular asymmetry factor; LDRa, arteriolar length-to-diameter ratio; LDRv, venular length-to-diameter ratio.
*P , .001; all P values corrected for false discovery rate.
yValue was statistically significant at P , .05 before FDR correction.
zCategorical predictor; all other predictors continuous.
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adjusted model. Our results are consistent with previous
null results from cross-sectional analyses of the milder
retinal vascular changes analyzed in the currently used
LBC1936 cohort [6–8].
The lack of associations between cognition and nonpa-
thological retinal variables may be because of the choice
of retinal measurements examined in the present study.
The development of pathological changes in the retinal
vasculature may be a greater determinant with greater sensi-
tivity to changes in cognitive ability in healthy sample
[2,35]. One of the conclusions drawn from theAtherosclerosis Risk in Communities Study [3] was that
pathological retinal features with the strongest association
with cognitive ability were those associated with blood–
retinal barrier breakdown, indicators of more severe retinal
microvascular disease (microaneurysms, retinal hemor-
rhages), suggesting an important potential pathophysiolog-
ical mechanism of cognitive impairment. The strength of
association with cognitive ability increases as vascular dis-
ease progresses, with relatively weak associations for
vascular caliber measurements and stronger for any retinop-
athy [35]. The retinal measurements examined in the present
study reflect milder microvascular changes [3,35] and
S. McGrory et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (2019) 500-509 507appear, at best, to be weakly related to cognitive ability or
change. However, given the large number of people
undergoing ‘nonpathological’ age-related cognitive
changes, its individual differences, and the potential attrac-
tion of retinal vascular parameters as a herald of worse
cognitive decline, the present study provides valuable null
results.
Another potential explanation for our findings is sam-
ple selectivity; that is, we may have missed some of the
less healthy individuals because they were less likely to
volunteer for the study, meaning that the individuals
who were recruited tended to be healthier with potentially
fewer retinal vascular changes or pathologies. It is
possible that this contributed to the lack of any relations
of retinal variables to cognition in our sample, although
effect sizes were small (b range 2.213 to .000), and
with the exception of AFv, none of these effects were
close to being statistically significant after adjustment
for FDR.
The follow-up period of six years is relatively brief to
detect effects on cognitive trajectories, although we stress
that such a period of change measured in such a large sample
is quite rare. Our sample demonstrates a limited degree of
cognitive change across the follow-up period. Changes
over a longer period of follow-up should be examined.
Follow-up retinal imaging of participants at an older age,
where more severe retinal pathologies would be common,
could provide a better opportunity to relate retinal features
to cognition in a slightly older sample with a greater preva-
lence of severe cognitive impairment, where stronger associ-
ations have been found [35]. Again, it was important to
establish the results at the age range and age-change period
carried out in this study, in a critical decade for acceleration
of cognitive loss.
To the best of our knowledge, no previous studies
have examined associations between such a range of
features of the retinal microvasculature and multiple
domains of cognition, each assessed with multiple well-
validated tests. Furthermore, our study uses latent cogni-
tive factors rather than individual tests’ scores, which
enabled us to reduce the influence of measurement error
[17]. The narrow age range of the LBC1936 minimizes
confounding of other variables by chronological age,
which can hamper the examination of predictors of
within-person cognitive aging [36]. Previous studies,
without the benefit of a narrow age cohort, may have in-
flated the apparent associations between retinal and
cognitive variables.
There are some limitations that may influence the gener-
alizability of the results. The LBC1936 is a healthy and high-
functioning sample with a restricted geographic range and
ethnic background. It is not possible to extrapolate from
this sample to a diseased population, patients presenting to
a cognitive or stroke clinic, for example, as they may have
associations between retinal changes and cognitive decline,being at a more advanced stage of disease. Because this is a
healthy sample, we were not able to examine the association
between retinal features and cognition in a sample with
vascular dementia. It may be possible that among a subgroup
of patients with vascular dementia, an association between
previous small-vessel structural changes and subsequent
vascular dementia could be detected. There is some debate
on the accuracy and repeatability of retinal measurements
of semi-automated systems [37–39]. Despite retinal
measurement using a validated semi-automated program
(VAMPIRE), there remains an element of subjective human
input which could affect measurement reliability. Further-
more, measurements from both eyes were averaged to create
a mean retinal measurement. The degree of interocular sym-
metry remains unclear and appears to vary by measurement
[7,40,41], which is another source of uncertainty for retinal
measurement.
Though largely null, we judge the present study’s re-
sults to be of value. There is increasing interest and focus
in identifying early and accessible retinal biomarkers of
age-related cognitive decline, and it is important to test
all stages of age-related decline in this exploration, and
to test healthy and disease-based groups. The present
study applied robust analytic methods and had a compre-
hensive range of cognitive tests and retinal measurements
applied to a large, age-restricted and well-characterized
sample. We conclude that, given this setting and methods,
quantitative retinal parameters cannot yet be used as asso-
ciates of the level of cognitive abilities at age 73 years, or
to predict the degree of nonpathological cognitive decline
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1. Systematic review: We reviewed the literature, using
publication databases, focusing on studies of retinal
microvasculature features and cognitive change.
We found no studies examining trajectories of
different cognitive domains and their associations
with a wide range of retinal vascular features.
2. Interpretation: There is increasing interest in the po-
tential of noninvasive imaging of the retina as a
method of providing information about the health
of the brain, and potentially, as a marker of risk for
cognitive decline. Our findings provide no evidence
to support the use of quantitative retinal vascular
measurements to predict nonpathological cognitive
change in healthy older individuals.
3. Future directions: We propose two approaches which
may provide a better opportunity to relate retinal fea-
tures to cognition: (1) examine age-related cognitive
decline over a longer period of follow-up, and (2)
make use of retinal imaging of participants at an
older age, when more severe retinal pathologies are
more common.References
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